A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
NCT02192983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242
Last updated 2015-12-03
Summary
This study is designed to assess what is the better neoadjuvant chemotherapy regimen for patients with initially unresectable locally advanced gastric cancer.
Conditions
- Locally Advanced Gastric Cancer
Sponsors & Collaborators
-
Tianshu Liu
lead OTHER
Principal Investigators
-
tianshu liu · Shanghai Zhongshan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- China
Study Locations
More Related Trials
-
Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer
NCT02512380 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
NCT02338518 ·Status: UNKNOWN ·Phase: PHASE3
-
Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
NCT05507658 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
NCT06506292 ·Status: RECRUITING ·Phase: PHASE2
-
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
NCT03229096 ·Status: UNKNOWN ·Phase: PHASE2
-
Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer
NCT01331928 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
NCT02071043 ·Status: COMPLETED ·Phase: PHASE2
-
New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX
NCT05715632 ·Status: UNKNOWN ·Phase: NA
-
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
NCT05593458 ·Status: RECRUITING ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
NCT05948449 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
NCT05536102 ·Status: RECRUITING ·Phase: PHASE2
-
Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
NCT04890392 ·Status: UNKNOWN ·Phase: PHASE2
-
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
NCT05264896 ·Status: RECRUITING ·Phase: PHASE3
-
Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer
NCT01665274 ·Status: TERMINATED ·Phase: PHASE2
-
Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy
NCT03322969 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma
NCT01711242 ·Status: COMPLETED ·Phase: PHASE2
-
SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer
NCT01583361 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
NCT05602935 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
NCT06023758 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer
NCT01364493 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer
NCT07132528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer
NCT02038621 ·Status: UNKNOWN ·Phase: PHASE2
-
XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma
NCT03355612 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer
NCT04982939 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer
NCT04908813 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2